Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Women’s Healthcare Market Forecast 2017-2027

Visiongain Ltd
Posted on: 01 Aug 17
Global Women’s Healthcare Market Forecast 2017-2027

PR Newswire

LONDON, August 1, 2017

LONDON, August 1, 2017 /PRNewswire/ --

Postmenopausal Osteoporosis, Hormonal Contraceptives, Menopause, Infertility, Endometriosis, Polycystic Ovary Syndrome

The revenue of the women's healthcare market in 2016 is estimated at $31.1bn and is expected to grow at a CAGR of 3.8% in the first half of the forecast period. Among various segments in the Women's Healthcare market, the Postmenopausal Osteoporosis segment dominated the Global Women's Healthcare market with a share of 36.99% in 2016.

     (Logo: )

How this report will benefit you:
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 154-page report you will receive 96 charts - all unavailable elsewhere.

The 154-page report provides clear detailed insight into the women's healthcare market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope: 

• Global Women's Healthcare market forecasts from 2017-2027

• This report also breaks down the revenue forecast and SWOT Analysis for the main submarkets:
• Postmenopausal Osteoporosis
• Hormonal Contraceptives
• Infertility
• Endometriosis
• Polycystic Ovary Syndrome

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
• The US and Latin America
• Japan
• The UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
• Rest of the World

• This report provides discussion on pipeline products in various stages of clinical trials and regulatory approval.

• This report also discusses the drivers, challenges and trends that affect the global women's healthcare market.

• Our study discusses the selected leading companies that are the major players in the global women's healthcare market.
• Bayer
• Eli Lilly
• Merck & Co.
• Pfizer
• Sanofi
• Amgen
• Novo Nordisk
• AbbVie
• Bristol-Myers Squibb (BMS)

Visiongain's study is intended for anyone requiring commercial analyses for the women's healthcare market. You find data, trends and predictions.

Buy our report today Global Women's Healthcare Market Forecast 2017-2027: Postmenopausal Osteoporosis, Hormonal Contraceptives, Menopause, Infertility, Endometriosis, Polycystic Ovary Syndrome.

To request a report overview of this report please email Sara Peerun at or call Tel: +44-(0)-20-7336-6100.

Or click on

List of Companies Mentioned in the Report: 



Adamis Pharmaceuticals

Agile Therapeutics



ANI Pharmaceuticals

Apothecus Pharmaceutical



Bristol-Myers Squibb (BMS)




Crinetics Pharmaceuticals Inc.

Dexa Medica Group


Eli Lilly


Ferring International Center

Ferring Pharmaceuticals

GlaxoSmithKline (GSK)

HLL Lifecare


Ligand Pharmaceuticals


Lupin Pharmaceuticals

Mayer Laboratories

Medicines 360

Merck & Co.

Merck KGaA

Merus Labs

Mylan Laboratories

Neurocrine Biosciences


Novo Nordisk

OPKO Health

Pantarhei Bioscience B.V.


Radius Health

Samsung Bioepsis



Sanofi Pasteur

Sanofi Synthelabo


Tarsa Therapeutics

Teva Pharmaceuticals

Warner Chilcott

To see a report overview please email Sara Peerun on

SOURCE Visiongain Ltd

PR Newswire

Last updated on: 01/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.